CRISPR Medicine

Ligandal

Main focus: Novel delivery technologies

Company stage: Pre-clinical

Diseases: Undisclosed

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: San Francisco, CA, US

Website: https://www.ligandal.com/


Ligandal is a US-based, privately held biotech company focused on improving delivery systems for gene therapies. Ligandal creates bioinspired nanomaterials that more effectively deliver CRISPR reagents into the nucleus of T cells, which is the company's main target cell. The nanomaterials are developed from ligand-binding motifs derived from natural proteins interacting with the protein of interest.

See the full view ...